Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Daré Bioscience Inc.

    NASDAQ: DARE · Real-Time Price · USD
    2.40
    0.00 (0.00%)
    At close: Jul 03, 2025, 3:47 PM
    2.39
    -0.42%
    After-hours: Jul 03, 2025, 03:47 PM EDT

    Daré Bioscience Statistics

    Share Statistics

    Daré Bioscience has 8.85M shares outstanding. The number of shares has increased by 3.56% in one year.

    Shares Outstanding

    n/a
    		 8.85M

    Shares Change (YoY)

    n/a
    		 3.56%

    Shares Change (QoQ)

    n/a
    		 1.72%

    Owned by Institutions (%)

    n/a
    		 9.11%

    Shares Floating

    n/a
    		 8.71M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,559

    FTD / Avg. Volume

    n/a
    		 6.19%

    Short Selling Information

    The latest short interest is 46.02K, so 0.52% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 46.02K

    Short % of Shares Out

    n/a
    		 0.52%

    Short % of Float

    n/a
    		 0.53%

    Short Ratio (days to cover)

    n/a
    		 1.63

    Valuation Ratios

    The PE ratio is -6.54 and the forward PE ratio is -2.46. Daré Bioscience's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -6.54

    Forward PE

    n/a
    		 -2.46

    PS Ratio

    n/a
    		 2709.74

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 5.5

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Daré Bioscience.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 0.85

    Quick Ratio

    n/a
    		 0.85

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.06

    Debt / FCF

    n/a
    		 0.27

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $465.9

    Profits Per Employee

    n/a
    		 $-193,047.62

    Employee Count

    n/a
    		 21

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 99.9%

    Stock Price Statistics

    The stock price has increased by -22.33% in the last 52 weeks. The beta is 1.21, so Daré Bioscience's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.21

    52-Week Price Change

    n/a
    		 -22.33%

    50-Day Moving Average

    n/a
    		 2.88

    200-Day Moving Average

    n/a
    		 3.16

    Relative Strength Index (RSI)

    n/a
    		 30.05

    Average Volume (20 Days)

    n/a
    		 25,167

    Income Statement

    In the last 12 months, Daré Bioscience had revenue of 9.78K and earned -4.05M in profits. Earnings per share was -0.48.

    Revenue

    n/a
    		 9.78K

    Gross Profit

    n/a
    		 -14.29M

    Operating Income

    n/a
    		 -23.45M

    Net Income

    n/a
    		 -4.05M

    EBITDA

    n/a
    		 -23.41M

    EBIT

    n/a
    		 -23.45M

    Earnings Per Share (EPS)

    n/a
    		 -0.48
    Full Income Statement

    Balance Sheet

    The company has 15.7M in cash and 1.3M in debt, giving a net cash position of 14.4M.

    Cash & Cash Equivalents

    n/a
    		 15.7M

    Total Debt

    n/a
    		 1.3M

    Net Cash

    n/a
    		 14.4M

    Retained Earnings

    n/a
    		 -175.29B

    Total Assets

    n/a
    		 18.62M

    Working Capital

    n/a
    		 -9.37M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 5.39M and capital expenditures -573.05K, giving a free cash flow of 4.82M.

    Operating Cash Flow

    n/a
    		 5.39M

    Capital Expenditures

    n/a
    		 -573.05K

    Free Cash Flow

    n/a
    		 4.82M

    FCF Per Share

    n/a
    		 0.57
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -239692.2% and -41430.9%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -239692.2%

    Pretax Margin

    n/a
    		 -41430897.38%

    Profit Margin

    n/a
    		 -41430.9%

    EBITDA Margin

    n/a
    		 -36184.25%

    EBIT Margin

    n/a
    		 -239687.24%

    FCF Margin

    n/a
    		 49276.38%

    Dividends & Yields

    DARE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for DARE is $12.5, which is 420.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $12.5

    Price Target Difference

    n/a
    		 420.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 1, 2024. It was a backward split with a ratio of 1:12.

    Last Split Date

    n/a
    		 Jul 1, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:12

    Scores

    Altman Z-Score

    n/a
    		 -16.95

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist